Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin CF Pre-treatment with AviClear Laser for Acne
NCT06376110Recruiting
- Sponsor
- Austin Institute for Clinical Research
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in acne vulgaris and seborrheic dermatitis (SD) comparing Silymarin CF + AviClear with Placebo + AviClear (2 arms). Primary endpoints: Change in Facial Acne Severity at Day 98 and Change in Subject Tolerability at Day 98. Started Apr 2024; status: recruiting.
02
Drugs
Silymarin CF
03
Conditions
acne vulgarisseborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT06376110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06376110.